Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response. [electronic resource]
Producer: 20180116Description: 365 p. digitalISSN:- 2041-1723
- Antineoplastic Agents -- therapeutic use
- Apoptosis
- Female
- Humans
- Myeloid Cell Leukemia Sequence 1 Protein -- antagonists & inhibitors
- Ovarian Neoplasms -- drug therapy
- Phosphatidylinositol 3-Kinases -- metabolism
- Systems Biology
- TOR Serine-Threonine Kinases -- metabolism
- X-Linked Inhibitor of Apoptosis Protein -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.